Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Global Clinical Trials Review, H1, 2019" provides an overview of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) clinical trials scenario. This report provides top line data relating to the clinical trials on Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Grunenthal GmbH

Johnson & Johnson

Pfizer Inc

Medtronic Plc

CSL Ltd

Bristol-Myers Squibb Co

Axsome Therapeutics Inc

Allergan Plc

Advanced Clinical Research Inc

Advanced Biomedical ...

Grunenthal GmbH

Johnson & Johnson

Pfizer Inc

Medtronic Plc

CSL Ltd

Bristol-Myers Squibb Co

Axsome Therapeutics Inc

Allergan Plc

Advanced Clinical Research Inc

Advanced Biomedical Research of America Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13

Top Five Countries Contributing to Clinical Trials in Europe 14

Top Countries Contributing to Clinical Trials in North America 15

Top Countries Contributing to Clinical Trials in Middle East and Africa 16

Top Countries Contributing to Clinical Trials in Central and South America 17

Clinical Trials by G7 Countries: Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in G7 Countries 20

Clinical Trials in G7 Countries by Trial Status 22

Clinical Trials by E7 Countries: Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials 24

Clinical Trials by Phase in E7 Countries 26

Clinical Trials in E7 Countries by Trial Status 27

Clinical Trials by Phase 29

In Progress Trials by Phase 30

Clinical Trials by Trial Status 31

Clinical Trials by End Point Status 33

Subjects Recruited Over a Period of Time 34

Clinical Trials by Sponsor Type 35

Prominent Sponsors 36

Top Companies Participating in Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials 38

Prominent Drugs 40

Latest Clinical Trials News on Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) 42

Feb 05, 2019: Tetra Bio-Pharma redefines quality standards for pharmaceutical grade cannabis-derived products 42

Clinical Trial Profile Snapshots 43

Appendix 92

Abbreviations 92

Definitions 92

Research Methodology 93

Secondary Research 93

About GlobalData 94

Contact Us 94

Source 95

List of Tables

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic ...

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 13

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 14

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, North America, Top Countries, 2019* 15

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 16

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 17

Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 18

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 20

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 22

Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 24

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 26

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 27

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Phase, 2019* 29

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 30

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 31

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 33

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 34

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 35

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 36

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 38

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 40

List of Figures

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Region (%), 2019* 9

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex ...

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Region (%), 2019* 9

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 12

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 14

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 15

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 16

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 17

Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 19

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 21

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 23

Proportion of Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 25

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 27

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 28

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 30

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 31

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 32

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 34

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 35

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 36

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 37

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 39

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 41

GlobalData Methodology 94

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports